Bridgeway Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,500
| Closed | -$129K | – | 1343 |
|
|
2023
Q4 | $129K | Hold |
10,500
| – | – | ﹤0.01% | 1204 |
|
|
2023
Q3 | $101K | Hold |
10,500
| – | – | ﹤0.01% | 1230 |
|
|
2023
Q2 | $94.5K | Sell |
10,500
-10,000
| -49% | -$90K | ﹤0.01% | 1264 |
|
|
2023
Q1 | $161K | Buy |
+20,500
| New | +$161K | ﹤0.01% | 1140 |
|
|
2020
Q2 | – | Sell |
-60,400
| Closed | -$462K | – | 1350 |
|
|
2020
Q1 | $462K | Hold |
60,400
| – | – | 0.01% | 798 |
|
|
2019
Q4 | $1.08M | Buy |
+60,400
| New | +$1.08M | 0.01% | 718 |
|
|
2019
Q2 | – | Sell |
-60,000
| Closed | -$1.72M | – | 1357 |
|
|
2019
Q1 | $1.72M | Hold |
60,000
| – | – | 0.02% | 584 |
|
|
2018
Q4 | $1.19M | Buy |
60,000
+19,000
| +46% | +$375K | 0.02% | 671 |
|
|
2018
Q3 | $907K | Hold |
41,000
| – | – | 0.01% | 923 |
|
|
2018
Q2 | $333K | Hold |
41,000
| – | – | ﹤0.01% | 1231 |
|
|
2018
Q1 | $389K | Buy |
+41,000
| New | +$389K | ﹤0.01% | 1149 |
|